Zobrazeno 1 - 1
of 1
pro vyhledávání: '"2019nCoV-301 Study Group"'
Autor:
Dunkle, Lisa M, Kotloff, Karen L, Gay, Cynthia L, Áñez, Germán, Adelglass, Jeffrey M, Barrat Hernández, Alejandro Q, Harper, Wayne L, Duncanson, Daniel M, McArthur, Monica A, Florescu, Diana F, McClelland, R Scott, Garcia-Fragoso, Veronica, Riesenberg, Robert A, Musante, David B, Fried, David L, Safirstein, Beth E, McKenzie, Mark, Jeanfreau, Robert J, Kingsley, Jeffrey K, Henderson, Jeffrey A, Lane, Dakotah C, Ruíz-Palacios, Guillermo M, Corey, Lawrence, Neuzil, Kathleen M, Coombs, Robert W, Greninger, Alex L, Hutter, Julia, Ake, Julie A, Smith, Katherine, Woo, Wayne, Cho, Iksung, Glenn, Gregory M, Dubovsky, Filip, 2019nCoV-301 Study Group
Publikováno v:
The New England journal of medicine, vol 386, iss 6
The New England Journal of Medicine
The New England Journal of Medicine
Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b–3 trials in the United Kingdom and South Africa,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8601f5f48b6dfa99a7ac2a1c0d2998
https://escholarship.org/uc/item/5kn0d0g8
https://escholarship.org/uc/item/5kn0d0g8
